The global Biopharmaceuticals Manufacturing
Consumables Testing Market size is expected to
reach USD 709.92 million by 2025 at a 12.1% CAGR, according to a new report by
Grand View Research, Inc. The market is driven by growing need for in-depth
assessment of raw materials for successful and rapid launch of the final product.
Rising awareness pertaining to internal standards as well as external
regulations in the biopharmaceutical industry is also aiding market growth.
In the past few years, there has been a
major paradigm shift from small chemical molecules to large biological
molecules. As a result, the biopharmaceutical industry is geared toward
exploring every aspect involved in the manufacturing process.
Regulatory and quality expectations for
best quality raw materials and intermediates continue to increase. This, in
turn, has pressurized vendors engaged in manufacturing of excipients and raw
materials to invest in standardizing functionality as well as establishing
sophisticated processes to consistently address the needs of final product
developers.
Browse
Details of Report @
https://www.grandviewresearch.com/industry-analysis/biopharmaceuticals-manufacturing-consumables-testing-market
https://www.grandviewresearch.com/industry-analysis/biopharmaceuticals-manufacturing-consumables-testing-market
Further key findings from the report suggest:
·
Based on service, compendial and
multi-compendial testing held the largest share owing to demand from various
manufacturers for raw materials that are compliant to regulatory standards
·
Testing services for Active Pharmaceutical
Ingredients (APIs) accounted for the largest revenue share owing to presence of
a wide range of services in this segment
·
Presence of a large number of biologics
manufacturing entities in U.S. has resulted in North America dominating the
global market in 2017. Rising competitive rivalry amongst market participants
is also attributive for the large share of this region
·
Asia Pacific is expected to emerge as the
fastest growing regional market, fueled primarily by expansion of the contract
service industry in several Asian countries. This is partly attributed to low
operating costs in these nations
·
Key service providers in the market include
Eurofins Scientific; Merck KGaA; Charles River; Agilent Technologies; and
Catalent, Inc. These service providers are engaged in contract partnerships
with major biopharmaceutical manufacturing companies.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment